Advances in CAR T-Cell Therapy for Leukemia, Lymphoma, and Myeloma: Where We Are and Where We Are Going

In this online program, experts discuss best practices and emerging strategies in CAR T-cell therapy for patients with leukemia, lymphoma, and myeloma. Watch the on-demand Webcast, download the slides from a dynamic CCO symposium in Orlando, and read expert commentaries to learn more about how to integrate CAR T-cells into your clinical practice.
person default
Stephen J. Schuster, MD
Program Director
Matthew J. Frigault, MD
James K. Kochenderfer, MD
Jae H. Park, MD
person default
Stephen J. Schuster, MD

On-Demand Webcast

In this interactive, CME-certified Webcast, experts review the latest updates in CAR-T cell therapy and offer their insights on current best practices for patients with hematologic cancers.

person default Stephen J. Schuster, MD
Program Director
Matthew J. Frigault, MD James K. Kochenderfer, MD Jae H. Park, MD
Physicians: maximum of 2.25 AMA PRA Category 1 Credits Released: January 30, 2020 Expired: January 29, 2021

ClinicalThought

Review my approach to CAR T-cell therapy—including considerations for patient candidacy and managing toxicities—illustrated with a patient case from my practice.

person default Stephen J. Schuster, MD Released: October 17, 2019

In this commentary, Matthew J. Frigault, MD, highlights key studies of CAR T-cell therapy that will be presented at the upcoming 2019 ASH annual meeting in Orlando.

Matthew J. Frigault, MD Released: December 4, 2019

Read expert answers to audience questions from a recent symposium on current best practices and emerging directions in CAR T-cell therapy.

Jae H. Park, MD Released: March 24, 2020

Downloadable Slidesets

Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with ALL.

Jae H. Park, MD Released: December 6, 2019

Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with lymphomas.

person default Stephen J. Schuster, MD Released: December 6, 2019

Download this slideset for expert perspectives on emerging strategies in the use of CAR T-cell therapy for patients with multiple myeloma.

James K. Kochenderfer, MD Released: December 6, 2019

Download this slideset for expert perspectives on managing toxicities associated with CAR T-cell therapy.

Matthew J. Frigault, MD Released: December 6, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Celgene Corporation
Kite, A Gilead Company

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?